← Back to headlines
IDEAYA Biosciences' PT Increased Following Positive OptimUM-02 Trial Readout
Wedbush has raised its price target for IDEAYA Biosciences, Inc. after the company announced positive results from its OptimUM-02 trial readout.
24 Apr, 13:41 — 24 Apr, 13:41
Sources
Showing 1 of 1 sources
